News

Everyday Health on MSN7h
A New Treatment for Late-Stage Melanoma Uses the Power of the Herpesvirus
A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.
The Munich Eye12h
Innovative Compounds Enhance Cellular Defense Against Viruses
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Managed Healthcare Executive13h
Next-Gen Oncolytic Virus Shows Potential to Treat Advanced Melanoma
The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.
Infectious Disease Advisor14h
Shingrix Vaccine Reduces Herpes Zoster Risk By 50% in Inflammatory Arthritis
Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.
Pharmaceutical Technology on MSN18h
FDA approves GSK’s prefilled syringe presentation of Shingrix
The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...